These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32023758)

  • 1. [Mechanism of STAT3 phosphorylation mediated leukemia cells resistance to doxorubicin].
    Jia ZX; Lu XZ; Cai XH; Qin W; Han WM; Xiao R; Zhou M; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):69-71. PubMed ID: 32023758
    [No Abstract]   [Full Text] [Related]  

  • 2. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
    Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
    BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors secreted by human neuroblastoma mediated doxorubicin resistance by activating STAT3 and inhibiting apoptosis.
    Rebbaa A; Chou PM; Mirkin BL
    Mol Med; 2001 Jun; 7(6):393-400. PubMed ID: 11474132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.
    Hira SK; Mondal I; Bhattacharya D; Gupta KK; Manna PP
    Int J Biochem Cell Biol; 2015 Oct; 67():1-13. PubMed ID: 26255115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress.
    Maryam A; Mehmood T; Zhang H; Li Y; Khan M; Ma T
    Sci Rep; 2017 Jul; 7(1):6242. PubMed ID: 28740138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.
    Liu Y; Li PK; Li C; Lin J
    J Biol Chem; 2010 Aug; 285(35):27429-27439. PubMed ID: 20562100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
    Liu Y; Liu X; Yang S
    Biol Pharm Bull; 2021 Jun; 44(6):861-868. PubMed ID: 33828027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.
    Wang Y; Cheng Z; Xu J; Lai M; Liu L; Zuo M; Dang L
    Bioengineered; 2021 Dec; 12(1):1874-1889. PubMed ID: 34076564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin.
    Zhou J; Ong CN; Hur GM; Shen HM
    Biochem Pharmacol; 2010 May; 79(9):1242-50. PubMed ID: 20026083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol enhances Doxorubicin-induced apoptosis in papillary thyroid carcinoma cells via regulating VDR/PTPN2/p-STAT3 pathway.
    Zhang T; He L; Wang Z; Dong W; Sun W; Qin Y; Zhang P; Zhang H
    J Cell Mol Med; 2020 May; 24(10):5629-5639. PubMed ID: 32285621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
    Wang J; Zhang G; Dai C; Gao X; Wu J; Shen L; Chen Z; Liu P
    J Int Med Res; 2017 Feb; 45(1):220-230. PubMed ID: 28222632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
    Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
    Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines.
    Kim JH; Lee SC; Ro J; Kang HS; Kim HS; Yoon S
    Biochem Pharmacol; 2010 Feb; 79(3):373-80. PubMed ID: 19766599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
    Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3005-3011. PubMed ID: 28742207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia.
    Mencalha AL; Corrêa S; Salles D; Du Rocher B; Santiago MF; Abdelhay E
    BMC Cancer; 2014 Nov; 14():866. PubMed ID: 25417721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
    Eiring AM; Page BDG; Kraft IL; Mason CC; Vellore NA; Resetca D; Zabriskie MS; Zhang TY; Khorashad JS; Engar AJ; Reynolds KR; Anderson DJ; Senina A; Pomicter AD; Arpin CC; Ahmad S; Heaton WL; Tantravahi SK; Todic A; Moriggl R; Wilson DJ; Baron R; O'Hare T; Gunning PT; Deininger MW
    Leukemia; 2015 Mar; 29(3):586-597. PubMed ID: 25134459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.